Artículos de revistas
Bay 41-2272 Activates Host Defence Against Local And Disseminated Candida Albicans Infections
Registro en:
Memorias Do Instituto Oswaldo Cruz. Fundacao Oswaldo Cruz, v. 110, n. 1, p. 75 - 85, 2015.
740276
10.1590/0074-02760140255
2-s2.0-84923121366
Autor
Soeiro-Pereira P.V.
Falcai A.
Kubo C.A.
Antunes E.
Condino-Neto A.
Institución
Resumen
In our previous study, we have found that 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3 -yl]-pyrimidin-4-ylamine (BAY 41-2272), a guanylate cyclase agonist, activates human monocytes and the THP-1 cell line to produce the superoxide anion, increasing in vitro microbicidal activity, suggesting that this drug can be used to modulate immune functioning in primary immunodeficiency patients. In the present work, we investigated the potential of the in vivo administration of BAY 41-2272 for the treatment of Candida albicans and Staphylococcus aureus infections introduced via intraperitoneal and subcutaneous inoculation. We found that intraperitoneal treatment with BAY 41-2272 markedly increased macrophage-dependent cell influx to the peritoneum in addition to macrophage functions, such as spreading, zymosan particle phagocytosis and nitric oxide and phorbol myristate acetate-stimulated hydrogen peroxide production. Treatment with BAY 41-2272 was highly effective in reducing the death rate due to intraperitoneal inoculation of C. albicans, but not S. aureus. However, we found that in vitro stimulation of peritoneal macrophages with BAY 41-2272 markedly increased microbicidal activities against both pathogens. Our results show that the prevention of death by the treatment of C. albicans-infected mice with BAY 41- 2272 might occur primarily by the modulation of the host immune response through macrophage activation. 110 1 75 85 Aiuti, A., Roncarolo, M.G., Ten years of gene therapy for primary immune deficiencies (2009) Hematology am Soc Hematol Educ Program, 2009, pp. 682-689 Bischoff, E., Schramm, M., Straub, A., Feurer, A., Stasch, J.P., BAY 41-2272: A stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo (2003) Urology, 61, pp. 464-467 Booth, C., Gaspar, H.B., Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID) (2009) Biologics, 3, pp. 349-358 Borán, M.S., Baltrons, M.A., García, A., The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells (2008) Glia, 56, pp. 394-411 Borán, M.S., García, A., The cyclic GMP-protein kinase G pathway regulates cytoskeleton dynamics and motility in astrocytes (2007) J Neurochem, 102, pp. 216-230 Chiesa, R., Veys, P., Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies (2012) Expert Rev Clin Immunol, 8, pp. 255-266 Cruz, G.V., Pereira, P.V., Patrício, F.J., Costa, G.C., Sousa, S.M., Frazão, J.B., Aragão-Filho, W.C., Nascimento, F.R., Increase of cellular recruitment, phagocytosis ability and nitric oxide production induced by hydroalcoholic extract from Chenopodium ambrosioides leaves (2007) J Ethnopharmacol, 111, pp. 148-154 De Oliveira-Júnior, E.B., Thomazzi, S.M., Rehder, J., Antunes, E., Condino-Neto, A., Effects of BAY 41-2272, an activator of nitric oxideindependent site of soluble guanylate cyclase on human NADPH oxidase system from THP-1 cells (2007) Eur J Pharmacol, 567, pp. 43-49 Ding, A.H., Nathan, C.F., Stuehr, D.J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production (1988) J Immunol, 141, pp. 2407-2412 D’ostiani, C.F., Del Sero, G., Bacci, A., Montagnoli, C., Spreca, A., Mencacci, A., Ricciardi-Castagnolic, P., Romania, L., Dendritic cells discriminate between yeast and hyphae of the fungus Candida albicans: Implications for initiation of T helper immunity in vitro and in vivo (2000) J Exp Med, 191, pp. 1661-1674 Erceg-Hurn, D.M., Mirosevich, V.M., Modern robust statistical methods: An easy way to maximize the accuracy and power of your research (2008) Am Psychol, 63, pp. 591-601 Errante, P.R., Frazão, J.B., Condino-Neto, A., The use of interferongamma therapy in chronic granulomatous disease (2008) Recent Pat Antiinfect Drug Discov, 3, pp. 225-230 Evgenov, O.V., Pacher, P., Schmidt, P.M., Haskó, G., Schmidt, H.H., Stasch, J.P., NO-independent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potential (2006) Nat Rev Drug Discov, 5, pp. 755-768 Flannagan, R.S., Cosío, G., Grinstein, S., Antimicrobial mechanisms of phagocytes and bacterial evasion strategies (2009) Nat Rev Microbiol, 7, pp. 355-366 Fried, A.J., Bonilla, F.A., Pathogenesis, diagnosis and management of primary antibody deficiencies and infections (2009) Clin Microbiol Rev, 22, pp. 396-414 Gupta, R., Bajpai, P., Tripathi, L.M., Srivastava, V.M., Jain, S.K., Misra-Bhattacharya, S., Macrophages in the development of protective immunity against experimental Brugia malayi infection (2004) Parasitology, 129, pp. 311-323 Hoernes, M., Seger, R., Reichenbach, R., Modern management of primary B-cell immunodeficiencies (2011) Pediatr Allergy Immunol, 22, pp. 758-769 Joshi, C.N., Martin, D.N., Fox, J.C., Mendelev, N.N., Brown, T.A., Tulis, D.A., The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMPdependent protein kinase and cGMP-dependent protein kinase pathways (2011) J Pharmacol Exp Ther, 339, pp. 394-402 Kinsman, O.S., White, M.I., Noble, W.C., Inflammatory reactions to staphylococcal protein A in mice (1981) Br J Exp Pathol, 62, pp. 142-145 Klein, J.P., Moeschberger, M.L., (2003) Survival Analysis: Techniques for Censored and Truncated Data, p. 538. , 2nd ed., Springer, New York Lu, Z., Xu, X., Hu, X., Fassett, J., Zhu, G., Tao, Y., Li, J., Chen, Y., PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload (2010) Antioxid Redox Signal, 13, pp. 1011-1022 Modell, V., Bonnie, G., Lewis, D.B., Orange, J.S., Roifman, C.M., Routes, J.M., Sorensen, R.U., Modell, F., Global study of primary immunodeficiency diseases (PI) - diagnosis, treatment and economic impact: An updated report from the Jeffrey Modell Foundation (2011) Immunol Res, 51, pp. 61-70 Morbidelli, L., Pyriochou, A., Filippi, S., Vasileiadis, I., Roussos, C., Zhou, Z., Loutrari, H., Papapetropoulos, A., The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor- induced angiogenesis and permeability (2010) Am J Physiol Regul Integr Comp Physiol, 298, pp. 824-832 Nguyen, L.N., Nguyen, T.G., Characteristics and outcomes of multiple organ dysfunction syndrome among severe-burn patients (2009) Burns, 35, pp. 937-941 Niska, J.A., Meganck, J.A., Pribaz, J.R., Shahbazian, J.H., Lim, E., Zhang, N., Rice, B.W., Miller, L.S., Monitoring bacterial burden, inflammation and bone damage longitudinally using optical and μCT imaging in an orthopaedic implant infection in mice (2012) Plos ONE, 7, pp. 473-497 Pick, E., Keisari, Y., A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture (1980) J Immunol Methods, 38, pp. 161-170 Pick, E., Mizel, D., Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader (1981) J Immunol Methods, 46, pp. 211-226 Pinello, K.C., Fonseca, E.S., Akisue, G., Silva, A.P., Oloris, S.C., Sakai, M., Matsuzaki, P., Dagli, M.L., Effects of Pfaffia paniculata (Brazilian ginseng) extract on macrophage activity (2006) Life Sci, 78, pp. 1287-1292 Proctor, G.B., Carpenter, G.H., Regulation of salivary gland function by autonomic nerves (2007) Auton Neurosci, 133, pp. 3-18 Rabinovitch, M., Manejias, R.E., Russo, M., Abbey, E.E., Increased spreading of macrophages from mice treated with interferon inducers (1977) Cell Immunol, 29, pp. 86-95 Reiter, M.J., Schwartzmiller, D.H., Swingle, K.F., Moore, G.G., Goldlust, M.B., Heghinian, K., Devore, D.P., Weppner, W.A., Comparison of anti-inflammatory compounds in the carrageenan induced paw edema model and the reversed passive Arthus model utilizing the same animal (1985) Life Sci, 36, pp. 1339-1346 Roy-Ghanta, S., Orange, J.S., Use of cytokine therapy in primary immunodeficiency (2010) Clin Rev Allerg Immunol, 38, pp. 39-53 Salvemini, D., Wang, Z.Q., Wyatt, P.S., Bourdon, D.M., Marino, M.H., Manning, P.T., Currie, M.G., Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation (1996) Br J Pharmacol, 118, pp. 829-838 Schmidt, E.P., Damarla, M., Rentsendorj, O., Servinsky, L.E., Zhu, B., Moldobaeva, A., Gonzalez, A., Pearse, D.B., Soluble guanylyl cyclase contributes to ventilator-induced lung injury in mice (2008) Am J Physiol Lung Cell Mol Physiol, 295, pp. 1056-1065 Soeiro-Pereira, P.V., Falcai, A., Kubo, C.A., Oliveira-Júnior, E.B., Marques, O.C., Antunes, E., Condino-Neto, A., BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes (2012) Br J Pharmacol, 166, pp. 1617-1630 Sokolovska, A., Becker, C.E., Stuart, L.M., Measurement of phagocytosis, phagosome acidification and intracellular killing of Staphylococcus aureus (2012) Curr Protoc Immunol, 14, pp. 14-30 Stasch, J.P., Becker, E.M., Alonso-Alija, C., Apeler, H., Dembowsky, K., Feurer, A., Gerzer, R., Schramm, M., NO-independent regulatory site on soluble guanylate cyclase (2001) Nature, 410, pp. 212-215 Tatefuji, T., Izumi, N., Ohta, T., Arai, S., Ikeda, M., Kurimoto, M., Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility (1996) Biol Pharm Bull, 19, pp. 966-970 Teixeira, C.E., Priviero, F.B., Claudino, M.A., Baracat, J.S., De Nucci, G., Webb, R.C., Antunes, E., Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: Interaction with nitric oxide (2006) Eur J Pharmacol, 530, pp. 157-165 Thorsen, L.B., Eskildsen-Helmond, Y., Zibrandtsen, H., Stasch, J.P., Simonsen, U., Laursen, B.E., BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats (2010) Eur J Pharmacol, 647, pp. 147-154 Vanuffelen, B.E., Van Der Zee, J., De Koster, B.M., Vansteveninck, J., Elferink, J., Sodium azide enhances neutrophil migration and exocytosis: Involvement of nitric oxide, cyclic GMP and calcium (1998) Life Sci, 63, pp. 645-657 Winter, C.A., Risley, E.A., Nuss, G.W., Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs (1962) Proc Soc Exp Biol Med, 111, pp. 544-547 Wohlfart, P., Malinski, T., Ruetten, H., Schindler, U., Linz, W., Schoenafinger, K., Strobel, H., Wiemer, G., Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase (1999) Br J Pharmacol, 128, pp. 1316-1322